MT

Mettler-Toledo International Inc.

MTDHealthcareNASDAQ

Diagnostics & Research · Last scanned Sep 8, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$4.03B
+4.0% YoY
Net Income
$869.2M
+0.7% YoY
EBITDA
$1.24B
+0.6% YoY
Free Cash Flow
$693.6M

Scan Results

Daily timeframe
6 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Aug 18 MACD Negative CrossoverHistogram -4.7227, negative momentum
Aug 17CONFIRMED MACD Negative CrossoverHistogram -3.0840, negative momentum
RSI OverboughtRSI 71.9, above 70, stock may be overbought
About Mettler-Toledo International Inc.

Mettler-Toledo International Inc. Valued at $26.95B, MTD is a large-cap name in its sector. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

Where MTD stands vs its 150-day and 200-day moving averages

As of the August 18, 2026 close, MTD finished 10.14% above its 150-day moving average ($1286.93) and 7.26% above its 200-day moving average ($1321.44). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is MTD overbought or oversold?

At the August 18, 2026 close, MTD's RSI(14) was 60.5, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$26.95B
P/E (TTM)30.31
Fwd P/E26.02
EPS$44.39
Beta1.22
52W Change+4.7%
Analysis

Mettler-Toledo International Inc. carries $2.14B in total debt against $51.4M in cash reserves — debt is roughly 41.6x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $693.6M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on assets of 21.1% further supports the picture of efficient asset utilization. Revenue has been relatively flat, moving from $3.92B (2022) to $4.03B (2025).

The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Mettler-Toledo International Inc.'s trajectory.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms